AuthorsPhelan, P J
Walshe, J J
Conlon, P J
AffiliationDepartment of Nephrology, Beaumont Hospital, Dublin 9, Ireland., firstname.lastname@example.org
Atrial Fibrillation/blood/complications/*drug therapy
Blood Coagulation/*drug effects
Brain Ischemia/etiology/*prevention & control
International Normalized Ratio
Length of Stay
Renal Dialysis/*adverse effects
Stroke/etiology/*prevention & control
MetadataShow full item record
CitationClin Nephrol. 2011 Mar;75(3):204-11.
AbstractBACKGROUND: There is a paucity of data concerning the risks associated with warfarin in hemodialysis (HD) patients. We compared major bleeding episodes in this group with HD patients not receiving warfarin and with a cohort of non-HD patients receiving warfarin. METHODS: A retrospective review of 141 HD patients on warfarin (HDW), 704 HD patients not on warfarin (HDNW) and 3,266 non-dialysis warfarin patients (NDW) was performed. Hospital admissions for hemorrhagic events and ischemic strokes were examined as was hospital length of stay and blood product use. INR variability was also assessed. RESULTS: The incidence rates for major hemorrhage per 100 patient years was 10.8 in the HDW group as compared to 8.0 in the HDNW (p = 0.593) and 2.1 in the NDW (p < 0.001) groups. Mean units of red blood cell transfusions required was higher in patients on dialysis with no significant difference between HDW and HDNW groups. The risk of ischemic stroke per 100 patient years was 1.7 in the HDW group as compared to 0.7 in the HDNW groups (p = 0.636) and 0.4 in the NDW (p = 0.003). The HDW group had higher inter-measurement INR variability compared to the NDW group (p = 0.034). In patients with atrial fibrillation, HDW group had a higher incidence of ischemic stroke than the NDW group (2.2 versus 0.4 events per 100 patient years; p = 0.024). CONCLUSIONS: This study confirms the higher bleeding risk associated with HD/ESRD but suggests that warfarin use in these patients may not add significantly to this risk. We also demonstrated high rates of ischemic stroke in HD patients despite warfarin use. SUMMARY: Our study compares the frequency of major hemorrhage and secondarily, ischemic stroke in HD patients receiving or not receiving warfarin, with non-HD patients receiving warfarin. The major finding was that frequency of hemorrhage was higher in HD patients receiving warfarin than in non-HD patients receiving warfarin, but not different in HD patients with or without warfarin. A secondary finding was that INR variability was significantly higher in HD patients than non-HD patients on warfarin.
- Variability of INR and its relationship with mortality, stroke, bleeding and hospitalisations in patients with atrial fibrillation.
- Authors: Lind M, Fahlén M, Kosiborod M, Eliasson B, Odén A
- Issue date: 2012 Jan
- D-Dimer versus International Normalized Ratio of Prothrombin Time in Ischemic Stroke Patients Treated with Sufficient Warfarin.
- Authors: Yamamoto R, Nakae Y, Tanaka F, Johkura K
- Issue date: 2016 Jul
- Optimal intensity of international normalized ratio in warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation.
- Authors: Yasaka M, Minematsu K, Yamaguchi T
- Issue date: 2001 Dec
- Association between warfarin use and incidence of ischemic stroke in Japanese hemodialysis patients with chronic sustained atrial fibrillation: a prospective cohort study.
- Authors: Wakasugi M, Kazama JJ, Tokumoto A, Suzuki K, Kageyama S, Ohya K, Miura Y, Kawachi M, Takata T, Nagai M, Ohya M, Kutsuwada K, Okajima H, Ei I, Takahashi S, Narita I
- Issue date: 2014 Aug
- Benefits and risks of anticoagulation resumption following traumatic brain injury.
- Authors: Albrecht JS, Liu X, Baumgarten M, Langenberg P, Rattinger GB, Smith GS, Gambert SR, Gottlieb SS, Zuckerman IH
- Issue date: 2014 Aug